Expression of DNA damage repair proteins like 53BP1 and RAD51 was also downregulated following treatment with pevonedistat (NEDD8-activating enzyme inhibitor) and belinostat (HDACi) in acute myeloid leukemia (AML). This evidence concerns the gene TP53BP1 and acute myeloid leukemia.